Kanamycin is an aminoglycoside antibiotic that has been widely used in human and veterinary medicine for the treatment of various infections. 1 However, like other aminoglycosides, kanamycin has a narrow therapeutic index, and abuse of this drug may cause nephrotoxicity, ototoxicity, neuromuscular blocking effects, and allergic reactions to it. 2, 3 In addition, kanamycin can enter the human body through the food chain, leading to antibiotic resistance from pathogenic bacterial strains. Therefore, residual kanamycin in food should be strictly controlled to eliminate these adverse effects. European Union (EU) has established the maximum residue limits for kanamycin in edible tissues, 100 μg/kg, and in milk, 150 μg/kg (approximately equal to 300 nM). 4, 5 Thus, a sensitive, selective, and simple method for the detection of residual kanamycin is highly demanded to ensure our health.
Recently, a series of analytical methods has been developed for the detection of residual kanamycin, such as highperformance liquid chromatography (HPLC), 6, 7 gas chromatography masss pectrometry (GC-MS) 8 and an enzymelinked immunosorbent assay (ELISA). 9 Although these methods provide satisfying detection performance, they often require expensive instrumentation, skilled personnel to accomplish the operational procedures and relatively large amounts of reagents. To overcome these issues, many methods have been developed recently to detect kanamycin based on a specific DNA aptamer. 10 Aptamers are single-stranded DNA or RNA that can bind target specifically. 11, 12 Compared with antibodies, aptamers are stable, economic and easy to synthesize. Since a DNA aptamer of kanamycin was reported by Song et al., 13 several types of aptamer-based sensors have been developed, including gold nanoparticle methods, [14] [15] [16] modified fluorescent groups methods 17 and electrochemical methods. [18] [19] [20] However, most of them still suffer from several limitations, such as sophisticated synthesis procedures, difficult modification of probe materials and sample matrix interference. Thus, a label-free, turn-on and convenient method is in urgent need.
The G-quadruplex structure is a tertiary structure of DNA formed by a G-rich nucleic acid sequence. 21 This structure plays an important role in genomic functions, including transcription, recombination and replication. [22] [23] [24] Interestingly, unlike triplex, duplex or single-stranded forms of DNA, G-quadruplex DNA can be selectively recognized by N-methyl mesoporphyrin IX (NMM). 25, 26 NMM is a commercially available unsymmetrical anionic porphyrin compound with weak fluorescence. However, the fluorescence intensity of NMM exhibits a dramatic enhancement upon binding to the G-quadruplex structure. 27, 28 The NMM/G-quadruplex DNA system can be utilized as an excellent and label-free signal reporter to develop sensors, as widely reported. [29] [30] [31] Inspired by these facts, we report on a simple label-free and turn-on fluorescence method to detect kanamycin using a specific DNA aptamer as a recognizer and a NMM/G-quadruplex DNA system as a reporter.
The principle of the proposed fluorescence method to detect kanamycin is illustrated in Scheme 1. We have designed two ssDNA, P1 and P2. In the ends of P1, containing a G-quadruplex DNA sequence (red in P1 of Scheme 1) a G-quadruplex structure motif can form. Also, the middle of P1 contains a complementary sequence of P2, which is a DNA aptamer of kanamycin, which has been reported by Song et al. 13 In the absence of kanamycin, two ssDNA, P1 and P2, hybridize with each other, hampering P1 to form the G-quadruplex structure.
Therefore, no fluorescence enhancement can be detected even after adding NMM. When kanamycin was added, it would bind to P2 specifically with high affinity, leading P1 to release from the P1-P2 complex. Then, P1 in a free single state could form a G-quadruplex DNA structure by self-folding in a way that binds NMM, which results in a remarkable fluorescence enhancement.
To confirm the feasibility of our strategy, the fluorescence † To whom correspondence should be addressed. In the present work, a simple design of a "label-free" fluorescence method for kanamycin was developed and explored based on a specific DNA aptamer as a recognizer and a NMM/G-quadruplex DNA system as a reporter. The titration experiment showed a linear detection range of 0.5 to 100 nM with a low detection limit of 0.5 nM. It also showed excellent selectivity in a selectivity experiment. It was then successfully employed to detect kanamycin in milk with a excellent reliability.
Keywords Kanamycin detection, G-quadruplex structure, DNA aptamer Rapid Communications emission spectra from 580 to 640 nm under different conditions were investigated. As shown in Fig. S1 , NMM showed the background fluorescence, itself (Fig. S1, black) . Also, a free P1 could form G-quadruplex DNA structures and bind with NMM while generating a high fluorescence intensity (Fig. S1 , green curve). When P1 and P2 hybridized with each other, P1 could not form G-quadruplex structures, and the fluorescence intensity sharply decreased from 322.9 to 153.4 of the relative fluorescence intensity (Fig. S1, red curve) . After kanamycin was then added, the fluorescence emission exhibited a obvious enhancement as 41.85% from 153.4 to 217.6 (Fig. S1, blue) , owing to kanamycin binding P2 specifically, and thus releasing P1 to form G-quadruplex DNA structures. The above results confirmed that the fluorescence intensity dramatic enhancement was indeed triggered by adding kanamycin to the P1-P2 complex. Therefore, the present strategy is feasible for detecting kanamycin.
Subsequently, an assay of kanamycin was carried out. Various concentrations of kanamycin (0 -300 nM) were added to the experimental system to test the detection range of this sensing strategy. As can be seen, the fluorescence intensity increased with the kanamycin concentrations up to 200 nM (Fig. S2) . Even at the low concentrations of 0.5 nM, about a 4.24% fluorescence enhancement was clearly observed at 610 nm. When the concentration of kanamycin increased to 200 nM, the fluorescence intensity could increase by about 44.85% from 153.4 to 223.2. This result indicated that the release of the G-quadruplex structure was highly dependent on the concentrations of kanamycin. Then, the fluorescence intensity signal change (F -F0) at 610 nm was studied in the presence of varying kanamycin concentrations (Fig. 1) . The results showed that the fluorescence intensity signal change (F -F0) increased proportionally to the concentrations of kanamycin within the 0.5 to 100 nM range (inset in Fig. 1 ). The regression equation is Y = 9.902 + 0.569X (R 2 = 0.983). The limit of our method for kanamycin was 0.5 nM, which was better than, or comparable to, values obtained by other methods (Table S1 ). In addition, this detection limit was also lower than that of the European Union (EU) which defined the maximum residue limit of kanamycin in milk (300 nM).
Additionally, the selectivity of our method was later evaluated by comparing the fluorescence intensity signal change (F -F0) in the presence of 50 nM different antibiotic drugs. As shown in Fig. 2 , only kanamycin resulted in a considerably large fluorescence intensity signal change (F -F0), while other antibiotic drugs yielded very little change. The peak selectivity of kanamycin and other antibiotic drugs had an extremely significant difference. The result was consistent with other reported detection methods of kanamycin based on the specific DNA aptamer of kanamycin. 14, 16, 17, 32 The above results showed that our proposed label-free and turn-on fluorescence strategy had a satisfactory selectivity of kanamycin over that of other antibiotic drugs.
With the ideal sensitivity and selectivity established in a reaction solution, our method was further applied to determination of kanamycin in milk. Using the standard addition method, kanamycin were spiked into kanamycin-free milk to achieve three standard samples, whose final concentations were 20, 50 and 80 nM, respectively. Before detection, the milk samples were briefly pretreated to remove protein by acetonitrile precipitation.
14 Then, our method was used to detect the concentrations of kanamycin so as to evaluate the feasibility in real samples. The results are given in Table 1 . The recoveries of the samples were in the range of 96.4 -112.9%. The satisfactory results indicated that this proposed method could be used to detect kanamycin in milk with little interference.
In summary, we developed a label-free and turn-on fluorescence method for convenient and highly sensitive detecting kanamycin based on a specific DNA aptamer as a Scheme 1 Schematic illustration of the label-free fluorescence method for kanamycin detection based on the DNA aptamer and NMM/G-quadruplex DNA system. P1 is G-quadruplex DNA. P2 is a DNA aptamer of kanamycin. recognizer and the NMM/G-quadruplex DNA system as a reporter. This method was simple and cost-effective, which did not need artificial modification fluorescence groups. The limit of detection in our method was 0.5 nM with a linear detection range from 0.5 to 100 nM. In addition, our new method exhibits great potential for the detection of kanamycin in milk. Taken together, our novel method provided an effective platform for kanamycin detection. 
